Please try another search
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company’s genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.
Name | Age | Since | Title |
---|---|---|---|
Bernard Courtieu | - | 2007 | CEO & Director |
Larry Yost | - | - | Director of IntegraGen, Inc. |
Francois Thomas | 67 | 2018 | Director |
Francois Blondel | - | 2020 | Director |
Jean-Michel Pimont | 66 | - | Observer of the Board of Directors |
Emmanuelle Deponge | 56 | 2018 | Director |
Alain Declercq | - | 2020 | Director |
Jean-Pol Detiffe | - | 2020 | Chief Strategy & Innovation Officer and Director |
Jean Stéphenne | - | 2020 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review